Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 116Other hematologic neoplasm 34Plasma cell 15Sarcoma 3Myeloid 3Thoracic 2CNS 2Gynecologic 1Dermatologic 1Breast 1

Conditions

Sarcoma 1Oligodendroglioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma 1Gliosarcoma 1Glioblastoma 1Dendritic Cell Sarcoma, Interdigitating 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Bendamustine Hydrochloride × Sarcoma × Clear all
NCT00823797 2017-07-07

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

University of Washington

Phase 2 Completed
45 enrolled 11 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma

NCT01118845 2013-07-04

Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma

SymBio Pharmaceuticals

Phase 2 Completed
63 enrolled 46 charts
LymphoidSarcoma

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT00204620 2007-04-20

Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)

University Hospital Tuebingen

Phase 2 Completed
28 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡